Citation Impact
Citing Papers
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature.
2009
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Deep Patient: An Unsupervised Representation to Predict the Future of Patients from the Electronic Health Records
2016 Standout
Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response
2009 StandoutNobel
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Non‐Steroidal Antiinflammatory Drugs and the Risk of Acute Myocardial Infarction
2006
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Rheumatoid arthritis
2018 Standout
Comparison of Oral Prednisolone/Paracetamol and Oral Indomethacin/Paracetamol Combination Therapy in the Treatment of Acute Goutlike Arthritis: A Double-Blind, Randomized, Controlled Trial
2007
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
2005
The Effectiveness of Mobile-Health Technologies to Improve Health Care Service Delivery Processes: A Systematic Review and Meta-Analysis
2013 Standout
Evidence-Based Management of Anticoagulant Therapy
2012
Why we need easy access to all data from all clinical trials and how to accomplish it
2011
Coronary Artery Stents: II. Perioperative Considerations and Management
2008
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Oral Anticoagulant Therapy
2012 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Endometriosis
2009 Standout
Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool
2016
Risk of Myocardial Infarction and Death Associated With the Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Among Healthy Individuals: A Nationwide Cohort Study
2008
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Prostaglandin receptors are mediators of vascular function in endometrial pathologies
2006
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Statin Safety: An Assessment Using an Administrative Claims Database
2006
Gout
2009 Standout
Data Resource Profile: The Danish National Prescription Registry
2016 Standout
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
2015 Standout
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Systematic review: coxibs, non‐steroidal anti‐inflammatory drugs or no cyclooxygenase inhibitors in gastroenterological high‐risk patients?
2005
Antithrombotic Therapy for VTE Disease
2012 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Prevention of Heart Failure
2008
Executive Summary
2012 Standout
The Danish National Patient Registry: a review of content, data quality, and research potential
2015 Standout
Finding and Appraising Evidence
2006
Prostaglandin F2α stimulates motility and invasion in colorectal tumor cells
2007
The use of NSAIDs in rheumatic disorders 2005: a global perspective
2005
Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA
2007
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer
2006 Standout
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis
2009
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials
2007
Improving Ambulatory Prescribing Safety with a Handheld Decision Support System: A Randomized Controlled Trial
2005
Eicosanoids and cancer
2010 Standout
Rheumatoid arthritis
2010 Standout
Cardiovascular Risk and Inhibition of Cyclooxygenase
2006
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes
2012
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer
2006
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Serum uric acid and the risk of cardiovascular and renal disease
2015
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
2009
Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults—a nationwide registry-based study
2010
Identification of undiagnosed inflammatory arthritis in a community health fair screen
2009
Industry sponsorship and research outcome
2012 Standout
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
COX-2 Inhibition Potentiates Antiangiogenic Cancer Therapy and Prevents Metastasis in Preclinical Models
2014
The Role of Anti-Inflammatory Drugs in Colorectal Cancer
2012
Cardiovascular Effects of the Cyclooxygenase Inhibitors
2007
Culture-Independent Analysis of Indomethacin-Induced Alterations in the Rat Gastrointestinal Microbiota
2006
Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling
2017 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising
2009 Standout
Gout
2021 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Direct-to-Consumer Advertising of COX-2 Inhibitors: Effect on Appropriateness of Prescribing
2005
Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD)
2018
Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation
2009
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Risk of serious NSAID‐related gastrointestinal events during long‐term exposure: a systematic review
2006
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis
2006
Industry sponsorship and research outcome
2017 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction
2006
Works of Gerald Levy being referenced
Patient and clinical characteristics associated with gout flares in an integrated healthcare system
2015
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study
2005
Effect of Urate-lowering Therapies on Renal Disease Progression in Patients with Hyperuricemia
2014
Development and evaluation of a patient self-report case-finding method for rheumatoid arthritis
2004
Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial
2018
Gastrointestinal Safety of Nonsteroidal Antiinflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors in Patients on Warfarin
2009
Predicting the risk of gastrointestinal bleeding due to nonsteroidal antiinflammatory drugs: NSAID electronic assessment of risk.
2003